8/14/2025 9:55:42 AM EU Pharmaceutical Law Reform: Council advances paediatric medicine reform with more flexible investigation plan proposals By Clarissa Junge-Gierse This article is part of our series covering the proposed reforms to the EU pharmaceutical legislation. To view the entire series, click...
8/4/2025 9:40:31 AM Council adopts its position on EU pharmaceutical law reform: focus on antimicrobials and transferable data exclusivity vouchers By Caroline Arrighi-Savoie Nour Saab Margot Pietri This article is part of a series covering updates to the proposed European Union (EU) pharmaceutical legislation reform, known as the...
7/16/2025 12:09:27 PM The European Commission’s draft for a Critical Medicines Act (CMA): Disruptive Changes in Public Procurement? By Clarissa Junge-Gierse Introduction On March 11, 2025, the European Commission introduced the Critical Medicines Act (CMA), a legislative proposal that...
7/8/2025 8:00:47 AM EU Pharmaceutical Law Reform: Key Changes on Advertising of Medicinal Products By Kevin Munungu In 2023, the European Commission proposed a comprehensive update of the key EU pharmaceutical legislation (the "Pharma Package") to...
6/20/2025 11:08:08 AM Council of the European Union adopts position on EU Pharma Package By Benedicte Mourisse Marc Martens Sarah Faircliffe On 4 June 2025, the Council of the European Union adopted its mandate for negotiations with the European Parliament on two European...
5/28/2025 3:09:47 PM UK Clinical Trials Regulations Overhaul By Pieter Erasmus On 12 December 2024, the Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were laid before Parliament. These were...
4/24/2025 2:39:17 PM Patents Court finds no infringement of ostomy bag patent, even under doctrine of equivalents test By Imogen Kelso Summary In the recent case of Salts Healthcare Ltd v Pelican Healthcare Ltd [2025] EWHC 497 (Pat), the Patents Court assessed the...
3/31/2025 10:23:09 AM Health Data Holders’ obligations under the EHDS: What, When, and How Will We Know. By Benedicte Mourisse Marc Martens On 5 March 2025, the European Health Data Space (EHDS) Regulation was officially published in the Official Journal of the European Union....
3/27/2025 4:54:41 PM China Releases Comprehensive Draft Data Exclusivity Rules for Comments By Alison Wong * This article was co-authored with Olivia Zhao from Bird & Bird Lawjay Shanghai association team. On 19 March 2025, the National...
2/21/2025 10:24:24 AM EPO Board of Appeal Decides Pig/Human Chimera Patent Offends Human Dignity By Quinn Liang Mario Subramaniam The EPO Board of Appeal (“BoA”) recently rejected a patent application relating to pig-human chimeras, concluding that the invention was...
2/19/2025 2:57:21 PM Increased risks for Australian life sciences businesses under the EU’s modernised product liability regime By Rebecca Currey Tom Johnston A recent EU directive will have significant consequences for Australian life sciences companies operating in Europe. Directive 2024/2853...
2/17/2025 8:30:15 AM A Sea Change for Pharma: EU's Urban Wastewater Treatment Directive and its Cost Implications By Marc Martens Kevin Munungu A new European directive is set to significantly impact pharmaceutical companies operating within the European Union. Directive (EU)...
2/11/2025 3:50:42 PM Medical Devices in the UK: Changes to Post-Market Surveillance By Sophie Vo Quinn Liang On 11 December 2024, the MHRA published an updated roadmap for the future of the regulatory framework for medical devices in the UK,...
2/11/2025 8:39:19 AM Strengthening Pharma IP: China’s Boost to Data and Market Exclusivity By Alison Wong * This article was co-authored with Olivia Zhao from Bird & Bird Lawjay Shanghai association team. On 3 January 2025, the General Office...
1/30/2025 9:28:21 AM New Policy for Compassionate Use Programs By Hester Borgers Maud van Haaren The Dutch Medicines Evaluation Board (MEB) has recently published a new policy for Compassionate Use Programmes (CUP).[1] To support the...
1/29/2025 11:15:40 AM First decision on the SPC manufacturing waiver by the Belgian courts By Domien Op de Beeck Camille Vanpeteghem On 23 December 2024, the Brussels enterprise court issued a first decision in Belgium on the so-called “SPC manufacturing waiver”. Under...